Compare MSTR & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSTR | HLN |
|---|---|---|
| Founded | 1989 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | 24524 |
| Industry | Computer Software: Prepackaged Software | Package Goods/Cosmetics |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.6B | 41.1B |
| IPO Year | 1998 | N/A |
| Metric | MSTR | HLN |
|---|---|---|
| Price | $110.02 | $8.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 1 |
| Target Price | ★ $343.77 | N/A |
| AVG Volume (30 Days) | ★ 18.3M | 9.8M |
| Earning Date | 05-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.94% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $463,456,000.00 | N/A |
| Revenue This Year | $5.22 | $6.55 |
| Revenue Next Year | $2.41 | $4.42 |
| P/E Ratio | ★ N/A | $49.05 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $105.00 | $8.65 |
| 52 Week High | $457.22 | $11.28 |
| Indicator | MSTR | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 32.42 | 40.92 |
| Support Level | $105.00 | $8.71 |
| Resistance Level | $192.21 | $10.05 |
| Average True Range (ATR) | 8.98 | 0.14 |
| MACD | -1.36 | 0.00 |
| Stochastic Oscillator | 0.60 | 28.18 |
Strategy Inc is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provides industry AI-powered enterprise analytics software. It has one reportable operating segment: the Software Business, which is engaged in the design, development, marketing, and sales of the company's enterprise analytics software platform through cloud subscriptions and licensing arrangements and related services (i.e., product support, consulting, and education). Geographically, the company operates in EMEA, U.S. and Other Regions, of which maximum revenue is derived from U.S..
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.